Is it safe to use anti-TNF-α agents for tuberculosis in children suVering with chronic rheumatic disease?

Rheumatology International

Volumn 32, Issue 9, 2012, Pages 2675-2679

  Kilic, Omer ^a   Kasapcopur, Ozgur ^a   Camcioglu, Yildiz ^a   Cokugras, Haluk ^a   Arisoy, Nil ^a   Akcakaya, Necala ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Anti tnf alpha treatment; Etanercept; Juvenile idiopathic arthritis; Tuberculosis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; COLCHICINE; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB; ISONIAZID; METHOTREXATE; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; SALAZOSULFAPYRIDINE; THALIDOMIDE; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ACID FAST BACTERIUM; ADOLESCENT; ANAMNESIS; ARTHRITIS; ARTICLE; CHILD; CHRONIC ARTHRITIS; CHRONIC IDIOPATHIC UVEITIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; DRUG USE; ENTHESITIS; ENTHESITIS RELATED ARTHRITIS; FEMALE; FOLLOW UP; GASTRIC SUCTION; HUMAN; INCIDENCE; INFANT; JUVENILE PSORIATIC ARTHRITIS; JUVENILE RHEUMATOID ARTHRITIS; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; SCHOOL CHILD; SKIN INDURATION; SPUTUM SMEAR; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE; TUBERCULIN TEST; TURKEY (REPUBLIC); UVEITIS;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ARTHRITIS; ARTHRITIS, JUVENILE RHEUMATOID; ARTHRITIS, PSORIATIC; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; LATENT TUBERCULOSIS; MALE; RADIOGRAPHY, THORACIC; RECEPTORS, TUMOR NECROSIS FACTOR; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES; TREATMENT OUTCOME; TUBERCULIN TEST; TUMOR NECROSIS FACTOR-ALPHA; TURKEY; YOUNG ADULT;

EID: 84866391855     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2030-8     Document Type: Article

References (24)

1. Weiss JE, Ilowite NT (2005) Juvenile idiopathic arthritis. Pediatr Clin North Am 52:413-442 (Pubitemid 40463661)
2. Beresford MW, Baildam EM (2009) New advances in the management of juvenile idiopathic arthritis-2: the era of biologicals. Arch Dis Child Educ Pract Ed 94:151-156
3. WHO Report (2007) Global tuberculosis control: surveillance, planning, Wnancing. WHO, Geneva
4. Sester U, Junker H, Hodapp T, Schütz A, Thiele B, Meyerhans A et al (2006) Improved efficiency in detecting cellular immunity towards M. tuberculosis in patients receiving immunosuppressive drug therapy. Nephrol Dial Transpl 21:3258-3268 (Pubitemid 44567103)
5. Arend WP (2001) Physiology of cytokine pathways in rheumatoid arthritis. Arthr Rheum 45:101-106 (Pubitemid 32280409)
6. Crum NF, Lederman ER, Wallace MR (2005) Infections associated with tumor necrosis factor-antagonists. Medicine (Baltimore) 84:291-302 (Pubitemid 41368482)
7. Gómez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD, BIOBADASER Group (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to signiWcant increase in tuberculosis risk: a multicenter activesurveillance report. Arthr Rheum 48:2122-2127 (Pubitemid 36959191)
8. Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO (2004) Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38:1261-1265 (Pubitemid 38608568)
9. Long R, Gardam M (2003) Tumour necrosis factor-inhibitors and the reactivation of latent tuberculosis infection. CMAJ 168:1153-1156 (Pubitemid 36543228)
10. Wallis RS, Broder M, Wong J, Beenhouwer D (2004) Granulomatous infections due to tumor necrosis factor blockade: correction. Clin Infect Dis 39:1254-1255 (Pubitemid 40169331)
11. Tubach F, Salmon-Céron D, Ravaud P, Mariette X (2005) The RATIO observatory: French registry of opportunistic infections, severe bacterial infections, and lymphomas complicating anti-TNF alpha therapy. Joint Bone Spine 72:456-460 (Pubitemid 41821398)
12. Saliu OY, Sofer C, Stein DS, Schwander SK, Wallis RS (2006) Tumor-necrosis-factor blockers: diVerential Effects on mycobacterial immunity. J Infect Dis 194:486-492 (Pubitemid 44162660)
13. Carmona L, Gómez-Reino JJ, Rodríguez-Valverde V, Montero D, Pascual-Gómez E, Mola EM et al (2005) Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthr Rheum 52:1766-1772 (Pubitemid 40852885)
14. Cagatay T, AydÂn M, Sunmez S, Cagatay P, Gulbaran Z, Gul A et al (2010) Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis. Rheumatol Int 30:1459-1463
15. Winthrop KL, Seigel JN, Jereb J, Taylor Z, Iademarco MF (2005) TB associated with therapy against tumor necrosis factor. the Committee. Arthr Rheum 52:2968-2974 (Pubitemid 41447075)
16. Yokota S, Mori M, Imagawa T, Murata T, Tomiita M, Itoh Y et al (2010) Guidelines on the use of etanercept for juvenile idiopathic arthritis in Japan. Mod Rheumatol 20:107-113
17. Mariette X, Salmon D (2003) French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers. Ann Rheum Dis 62:791 (Pubitemid 36886422)
18. British Thoracic Society Standards of Care Committee (2005) BTS recommendations for assessing risk and for managing Mycobactcerium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment. Thorax 60:800-805
19. American Thoracic Society (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 161:221-247
20. Beglinger C, Dudler J, Mottet C, Nicod L, Seibold F, Villiger PM et al (2007) Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy. Swiss Med Wkly 137:620-622
21. Vukmanovic-Stejic M, Reed JR, Lacy KE, Rustin MH, Akbar AN (2006) Mantoux test as a model for a secondary immune response in humans. Immunol Lett 107:93-101 (Pubitemid 44779813)
22. Kiray E, Kasapcopur O, Bas V, Kamburoglu-Goksel A, Midilli K, Arisoy N et al (2009) PuriWed protein derivative response in juvenile idiopathic arthritis. J Rheumatol 36:2029-2032
23. Ayaz NA, Demirkaya E, Bilginer Y, Ozcelik U, Cobanoglu N, Kiper N et al (2010) Preventing tuberculosis in children receiving anti-TNF treatment. Clin Rheumatol 29:389-392
24. Cagatay T, Kilicaslan Z, Cagatay P, Mertsoylu M, Gulbaran Z, Yildiz R et al (2010) TNF-alpha antagonist therapy modify the tuberculin skin test response. Rheumatol Int Mar 27 (Epub ahead of print)